Drugs / S205
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00562237 | Jul → Nov 2007 | — | Solvay Pharmaceuticals | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | S205 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00562237 ↗ |
| Route | Intramuscular | “2 i.m. injections per subject” NCT00562237 ↗ |